Hematology-Oncology
Integrating Genetics and Measurable Residual Disease to Optimize Therapy in Philadelphia Chromosome-Negative Adult ALL
Combining genetic risk stratification with measurable residual disease enables precise treatment allocation in adult Philadelphia chromosome-negative acute lymphoblastic leukemia, improving survival outcomes and guiding the use of allogenei
